w">http://www.arrowt.co.uk.
For further information, please contact Dr Per Kallblad, CEO Beactica,
+46(0)730-674488, or Dr Ken Powell, CEO Arrow Therapeutics,
+44(0)207015-1000.
'/>"/>SOURCE Beactica AB Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 Related medicine news :1.
HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness2.
CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael3.
UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West4.
HEI, Inc. Announces Sale of RFID Division Assets5.
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)6.
Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference7.
Z Trim Announces Revocation of Gregory Halpern Severence Agreement8.
Brooke Franchise Corporation Announces Selected July Results9.
Manor Care, Inc. Announces Record Date for Special Stockholder Meeting10.
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)11.
Planet Technologies Announces Agreement to Acquire Antigen Laboratories